CClinicalTrials.gg
Status unknownNCT01285206Updated Jan 27, 2011

Carbon Polymer Blankets to Prevent Incidence Of Peri-Operative Hypothermia (IPH) in the DSU

An interventional study of Carbon polymer warming blanket in Hypothermia, sponsored by Brighton and Sussex University Hospitals NHS Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-01-27.

Sponsored by Brighton and Sussex University Hospitals NHS Trust · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2010), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients whose temperature drops below 36.0 degrees Centigrade during or after surgery suffer more complications, such as wound infections and increased blood loss, resulting in more blood transfusions and longer hospital stays than those who don't.

There is evidence that even a drop below 36.5 degrees Centigrade is sufficient to cause significant adverse effects. Although there is much evidence regarding the effectiveness of warming for long operations, there is nothing looking at short procedures such as those undertaken in the daysurgery setting.

A new carbon polymer blanket (HotDog Augustine Biomedical and Design) has been shown, in volunteer studies, to be as effective as forced air warming blankets (which are used for long operations) in preventing hypothermia. In contrast to forced air, the carbon polymer is reusable and has lower running-costs so is likely to be cheaper in the long term. This is particularly relevant in the day surgery setting where high numbers of patients are operated on. Additionally, and unlike the forced air warmers, the blanket can run on a battery so it can be applied from the moment the patient goes to sleep to the moment they wake up so it could actually prove more effective at preventing hypothermia in the clinical setting. This study aims to determine whether the carbon polymer blankets can reduce the incidence of hypothermia in the day surgery (ie. short operating time) setting.

Read the detailed description

Recently published NICE guidelines recommend using fluid warmers for all infusions of 500mls or more and forced-air warming blankets for all main theatre operations. These guidelines have been extrapolated from work done on longer operations.

Patients whose temperature drops below 36 degrees Centigrade during or after surgery suffer more complications and blood loss than those whose temperature remains above 36 degrees Centigrade. They also often require more blood transfusions and stay in hospital for longer. Some of these complications are more common even when the temperature drops below 36.5.

Disposable forced-air warming blankets prevent hypothermia, but cannot be re-used and therefore incur a significant expense in terms of consumables.

Re-usable carbon polymer blankets, such as the HotDog, have been shown to not only be effective in preventing hypothermia, but have also been shown to maintain core temperature as effectively as forced air blankets.

Carbon polymer blankets are re-usable, with the added associated benefit of lower running costs. Therefore, in the face of limited NHS resources a reusable money saving alternative, such as the carbon polymer HotDog, would be a preferred option to the disposable forced air blanket.

The current data on the effectiveness of the carbon polymer blanket is from volunteers. This study is actually powered to show a reduction in the number of patients who get cold in a clinical setting.

References:

NICE. Perioperative hypothermia (inadvertent): the management of inadvertent peri-operative hypothermia in adults.NICE Clinical Guideline 29. London: National Institute for Health and Clinical Excellence, 2008. http://www.nice.org.uk/GC065.

Schmeid H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. The Lancet 1996; 347:289-92.

Rajagopalan S, Mascha E, Na J, Sessler DI: The Effects of Mild Perioperative Hypothermia on Blood Loss and Transfusion Requirement. Anesthesiology 2008;108:717.

02

Conditions studied

  • Hypothermia

Browse trials for

03

In context

Hypothermia

499 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 70 is below the median of 80 across 351 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Brighton and Sussex University Hospitals NHS Trust is the lead sponsor of 22 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All patients, who are scheduled for non-emergency daycase surgery which will take place with them in the supine position

Exclusion criteria

Exclusion Criteria:

  • Those patients who refuse
  • Who are unable to fully understand the trial and give valid
  • Informed consent; OR
  • Who will not be positioned supine on the operating table
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Routine practice

    Device: Carbon polymer warming blanket

Interventions

  • DeviceCarbon polymer warming blanket

    Routine practice ( + no carbon polymer blanket) versus use of HotDog carbon polymer warming blanket throughout day surgery procedure

    Also known as: HotDog warming blanket

06

What researchers measure

Primary outcomes

  1. Core temperature

    Temperatures will be taken: Preoperatively on the day case unit ward, At the beginning of the operation Every 15 minutes thereafter intraoperatively. At the end of the operation in recovery Every 30 minutes until discharged home.

    Time frame: Every 15 minutes

Secondary outcomes

  1. Total blood loss

    Total blood loss will be recorded by surgical team. Blood collected in suction cannister and estimated blood loss from surgical swab wet vs. dry weight

    Time frame: At the end of the operative procedure

  2. Blood transfusion

    Whether a blood transfusion has taken place as a direct consequence of the operation will be recorded in the patients notes. The type and amount of blood products given will also be recorded in the patients notes and by the hospital blood bank services

    Time frame: From the start of the operation until discharge. If patient is re-admitted within 24 hours requiring blood transfusion - also be counted

  3. Wound infection

    The development of a wound infection will either be recorded in the patient's notes if associated with the patient's hospital stay, or the information will be obtained from the GP follow-up phone-call.

    Time frame: Upon patient discharge/ At GP follow-up at one month

  4. Shivering (need for treatment or not)

    The occurrence of shivering (andneed for treatment or not) will be recorded by the recovery staff on the questionnaire sheets

    Time frame: Recorded during recovery stay

  5. Time in recovery

    This will recorded by the recovery staff as entry time and discharge time from recovery.

    Time frame: Recorded during recovery stay

  6. Time taken for patient to be considered fit for discharge i.e. length of hospital stay.

    This data will be taken from the patient's notes: operation date until date of (fit for) discharge from hospital

    Time frame: Upon discharge from hospital

07

Study locations

1 of 1 sites recruiting
  • Brighton and Sussex University Hospitals NHS Trust
    Brighton, East Sussex, United Kingdom
    • Mark C Harper, MBBS · Principal investigator
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01285206
Lead sponsor
Brighton and Sussex University Hospitals NHS Trust
First posted
Jan 27, 2011
Start date
Dec 2010
Primary completion
Mar 2011 (estimated)
Completion
Mar 2011 (estimated)
Last update
Jan 27, 2011

Study contacts

Manu N Sharma, MBBS
Contact
mpns@doctors.org.uk
C. Mark Harper, MBBS
Contact
mark.harper@doctors.org.uk
C. Mark Harper, MBBS
study director · Brighton and Sussex University Hospitals NHS Trust

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion